Industries / Biotech and life science
Biotech patents that
survive due diligence
In life sciences, the patent often is the company. Lightbringer pairs expert biotech patent attorneys with agentic AI so your first filing protects the science, satisfies investors, and doesn't consume the runway.
The patent question arrives before the data does
Most life sciences founders know they need a biotech patent attorney. Fewer know when. The pattern we see: a promising result, a conference abstract, a grant application, and the disclosure clock starts before anyone has checked what's protectable.
Three mistakes show up again and again:
Treating the patent as a legal box.
Investors read your patent estate as a proxy for defensibility. A thin, rushed filing raises questions in the data room that a good one answers.
Claiming the molecule, not the method.
A composition claim is the headline. The manufacturing method, the dosing regimen, and the diagnostic use are often where the durable value sits.
Publishing first, filing second.
A poster session or preprint can end novelty in most jurisdictions. A conference talk can count as public disclosure. Filing a provisional application before you present costs a fraction of what it protects.
Life sciences patents across the pipeline
Diagnostics and tools
Assays, biomarkers, sequencing methods, and lab instruments. Including the software and algorithms that turn a signal into a result.
Therapeutics and biologics
New chemical entities, antibodies, peptides, formulations, and methods of treatment. Claims drafted to hold up against the prior art that already exists in your target.
Cell, gene, and synthetic biology
Engineered organisms, gene editing methods, vectors, and bioprocesses. Areas where claim scope and enablement need an attorney who has drafted in them before.
Medtech and devices
Implantables, wearables, drug delivery systems, and surgical tools. We work at the intersection of mechanical, electronic, and clinical claims.
From lab notebook to filed application
Disclose in plain language
Describe what you built and why it matters in the Lightbringer platform. No legal templates. Our agentic AI structures the disclosure and runs an initial novelty search against existing literature and patents.
Your attorney takes over
A dedicated patent attorney with life sciences experience reviews the search, sets the claim strategy with you, and drafts the application. AI does the heavy lifting on search and drafting. The attorney handles judgement. Meet the attorneys
File, prosecute, and keep going
We file, respond to examiner objections, and manage every deadline through to a decision on grant. You see the status of every filing in one place, alongside the rest of your portfolio as it grows.
Built for founders, not for billable hours
One flat fee per application
$7,200 per patent application per year covers strategy, drafting, filing, and prosecution to a decision on grant. Official patent office fees are the only extra. You know the cost before you commit, which matters when every dollar is runway.
Attorneys who read the science
Every Lightbringer patent is reviewed and approved by a qualified patent attorney. Our team has worked inside global enterprises, research labs, and high-growth startups, and understands molecular research, diagnostics, and medtech development.
A patent estate investors can read
Your portfolio, filings, deadlines, and strategy live in one platform. When due diligence starts, you share a live view instead of assembling a folder of PDFs the night before.
Trusted by 100+ founders in 20+ countries
EIC-funded health and biotech companies
Go deeper on life sciences patents
Ready to protect the science before someone else does?
Sign up, describe your invention, and get a patentability view before you talk to anyone.